ONEMEDNET CORP
ONMDNASDAQTrading Snapshot
- Day Range
- $4.41 – $5.08
- 52-Week Range
- $3.61 – $23.00
- Volume (shares)
- 8,275
- Avg Volume (shares)
- —
- Shares Outstanding
- 6.0M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $1M
- Last Q Revenue
- $292,000
- P/E Ratio
- —
- P/S Ratio
- 20.0x
- EPS (TTM)
- $-1.41
- Dividend Yield
- —
- Dilution (1yr)
- +59.2%
ONEMEDNET CORP
ONMDAbout ONEMEDNET CORP
OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

OneMedNet Reports Third Quarter 2026 Financial Results and Reiterates Fourth Quarter 2026 Outlook
MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-

Claritev (NYSE:CTEV) vs. OneMedNet (NASDAQ:ONMD) Head-To-Head Analysis
Claritev (NYSE: CTEV - Get Free Report) and OneMedNet (NASDAQ: ONMD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of th

OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap
MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-

OneMedNet Partners to Combine First-Party Multimodal Clinical Data with Comprehensive Patient-Journey AI Analytics, Expanding Commercial Reach Through 13th Channel Partnership
MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
MINNEAPOLIS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-

OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models
MINNEAPOLIS, Nov. 04, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-